Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 41 - 60 of 292
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jun 2019, 7:39 am by Samuel B. Friedman, Esq.
Merrell Dow Pharmaceuticals, Inc.[2], the Court ruled that Rule 702 of the Federal Rules of Evidence did not incorporate the Frye general acceptance test as a basis for assessing scientific testimony. [read post]
7 Jun 2019, 7:39 am by Samuel B. Friedman, Esq.
Merrell Dow Pharmaceuticals, Inc.[2], the Court ruled that Rule 702 of the Federal Rules of Evidence did not incorporate the Frye general acceptance test as a basis for assessing scientific testimony. [read post]
30 Jan 2011, 5:29 pm by Scott Koller
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
28 Jul 2011, 11:19 am by Bexis
  He didn't file suit, however, until June 2009.Dead to rights under the Texas two-year statute of limitations, plaintiff tried to argue that his claim didn't "accrue" until there was scientific evidence sufficient to satisfy Texas' version of Daubert, which was imposed in Merrell Dow Pharmaceuticals, Inc. v. [read post]
11 Oct 2018, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), an increasing number of expert witnesses have been challenged by way of a Daubert motion. [read post]
7 Mar 2016, 8:51 am by Mehjabeen Rahman
Merrell Dow Pharmaceuticals, Inc.,  509 U.S. 579 (1993), that is relevant in determining the admissibility of such testimony. [read post]
13 Mar 2018, 6:00 am by Christine Funk
Fleetwood Homes of Pennsylvania, Inc., 878 A.2d 509 (Me. 2005) although more Daubert than Frye. [read post]
29 Jun 2020, 12:41 pm by Jim Robinson
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
18 Jun 2019, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which focuses on an analysis of enumerated factors when determining expert admissibility. [read post]